Evaluation of CD4+, CD39+, FOXP3+ T Regulatory Cells in Iraqi Alopecia Areata Patients by ELISA

    October 2022 in “ Journal of pharmaceutical negative results ”
    Omer Khudair Rhadi, Hayfaa Mahmud Fahad
    Studysummary This study found that patients with Alopecia areata in Iraq had significantly higher levels of CD4+, CD39+, and FOXP3+ Treg cells in their blood compared to healthy controls.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pnrjournal.com →
    Discuss this study in the Community →

    Related research 7

    1. Hydroxychloroquine for Granuloma Annulare: A Case Report on Secondary Hair Growth in Alopecia Universalis SAGE Open Medical Case Reports · 2023
    2. Evaluation of CD4+, CD39+, FOXP3+ T Regulatory Cells in Iraqi Alopecia Areata Patients by ELISA Journal of pharmaceutical negative results · 2022
    3. Efficacy of Systemic Minoxidil and Tofacitinib Combination in Treatment-Resistant Alopecia Universalis Journal of Cosmetic Dermatology · 2020
    4. Comparison of Quality of Life Using Hair-Specific Skindex-29 Between Androgenetic Alopecia and Alopecia Areata Journal of The American Academy of Dermatology · 2016
    5. Alopecia Areata Treated With Topical Minoxidil Archives of Dermatology · 1984
    6. Topical Minoxidil in the Treatment of Alopecia Areata BMJ · 1983
    7. PUVA Therapy for Alopecia Areata 1981